Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atmospheric Glow Technologies (AGT) was a specialized biotechnology and medical device company focused on the development of "cold" atmospheric pressure plasma technology. Spun out from the University of Tennessee, the company commercialized the One Atmosphere Uniform Glow Discharge Plasma (OAUGDP) platform, which allows for the generation of plasma at room temperature and normal atmospheric pressure. This breakthrough technology was primarily utilized for the sterilization of heat-sensitive medical instruments, decontamination of biological agents, and the creation of antimicrobial surfaces. The company's innovations provided a non-toxic, dry alternative to traditional chemical and heat-based sterilization methods. AGT was acquired by Kimberly-Clark in 2004 to integrate its plasma technology into healthcare and professional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atmospheric Glow Technologies.